Centessa Pharmaceuticals (CNTA) Return on Sales (2022 - 2025)
Historic Return on Sales for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Q3 2025 value amounting to 16.18%.
- Centessa Pharmaceuticals' Return on Sales fell 789300.0% to 16.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.18%, marking a year-over-year decrease of 789300.0%. This contributed to the annual value of 22.05% for FY2023, which is N/A changed from last year.
- As of Q3 2025, Centessa Pharmaceuticals' Return on Sales stood at 16.18%, which was down 789300.0% from 15.36% recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Return on Sales ranged from a high of 62.75% in Q3 2024 and a low of 16.18% during Q3 2025
- Moreover, its 4-year median value for Return on Sales was 18.95% (2022), whereas its average is 18.78%.
- In the last 5 years, Centessa Pharmaceuticals' Return on Sales skyrocketed by 475400bps in 2024 and then plummeted by -789300bps in 2025.
- Centessa Pharmaceuticals' Return on Sales (Quarter) stood at 19.6% in 2022, then decreased by -27bps to 14.33% in 2023, then soared by 338bps to 62.75% in 2024, then crashed by -126bps to 16.18% in 2025.
- Its last three reported values are 16.18% in Q3 2025, 15.36% for Q2 2025, and 1.74% during Q1 2025.